NCT07209748View on ClinicalTrials.gov

sCD163 in HELLP Syndrome

Not yet recruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

February 28, 2027

Conditions
HELLP Syndrome Complicating Pregnancy
Interventions
DIAGNOSTIC_TEST

sCD163 level

The significance of soluble CD163 level in the early detection and severity assessment of HELLP Syndrome

All Listed Sponsors
lead

Assiut University

OTHER

NCT07209748 - sCD163 in HELLP Syndrome | Biotech Hunter | Biotech Hunter